Latest filing published 10 Oct 2012 for Renasant CORP, €114k.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -7.5%Entry US$20.73 · Close at T+365 US$19.18
- -2.5%Entry US$18.50 · Close at T+365 US$18.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Claude H. Springfield III: trading record in brief
Claude H. Springfield III appears in our data through filings on Renasant Corp shares, published by SEC (Form 4). In total, 24 filings cover trades dated from 17 January 2006 to 8 October 2012.
Market trades split into 3 purchases (€28k) and 4 sales (€190k). Netting one side against the other leaves €162k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 12 share grants and 1 option exercise.
A typical purchase (the median) is worth €7,223. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +4.1%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 10 October 2012, reports an option exercise of €114k in Renasant Corp. The last insider purchase was made public on 6 August 2007, 7,035 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Claude H. Springfield III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,875 shares@ US$18.77Common StockSEC:0001209191-12-048985:0
- 7,577 shares@ US$19.44Common StockSEC:0001209191-12-048985:1
- 1,500 shares@ US$16.91Common Stock (Performance Based Restricted)SEC:0001209191-12-004397:0
- 1,500 shares@ US$16.91Common Stock (Performance Based Restricted)SEC:0001209191-11-004114:0
- 2,000 shares@ US$18.00Common StockSEC:0001209191-10-056002:0
- 5,000 shares@ US$20.45Common StockSEC:0001209191-08-058100:0
- 3,000 shares@ US$21.00Common StockSEC:0001209191-08-058100:1
- 900 sharesCommon StockSEC:0000715072-08-000039:0
- 500 shares@ US$19.00Common StockSEC:0000715072-07-000098:0Canonical exit: 1 Nov 2007 (T+90)
- 1,000 shares@ US$18.75Common StockSEC:0000715072-07-000098:1Canonical exit: 2 Nov 2007 (T+90)
- 500 shares@ US$19.75Common StockSEC:0000715072-07-000091:0Canonical exit: 28 Oct 2007 (T+90)
- 1,500 sharesCommon Stock (Restricted Stock)SEC:0000715072-07-000024:0
- 1,000 shares@ US$44.50Common StockSEC:0000715072-06-000119:0
- 1,000 sharesCommon StockSEC:0000715072-06-000032:0
- 3,000 sharesCommon StockSEC:0000715072-06-000025:0
15 of 15 declarations